Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Apr 4;44(9):1001–1013. doi: 10.1093/asj/sjae073

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2024. Published by Oxford University Press on behalf of The Aesthetic Society.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 3. — Treating investigator–reported GAIS responder rate at each study visit following HA_EYE treatment (observed cases; ITT population). A responder was defined as a patient who indicated that their appearance was “improved,” “much improved,” or “very much improved” on the GAIS. An optional additional HA_EYE treatment was offered at Month 12 to patients already treated at baseline in whom optimal aesthetic improvement had not been maintained, and to patients in the control group. Only patients who had HA_EYE retreatment/treatment at Month 12 attended visits at Months 13, 15 and 18 (corresponding to 1, 3, and 6 months after retreatment/treatment at Month 12). The ITT population included all patients who were randomized at baseline. HA_EYE-pooled included all patients receiving HA_EYE treatment by needle or cannula. GAIS, Global Aesthetic Improvement Scale; HA_EYE, Restylane Eyelight hyaluronic acid treatment; ITT, intention-to-treat.